Health Care · NYSE/Nasdaq. Last price 166.43 USD (-0.06% on the day). Raven's AI 12-month target: 180.00 USD. Updated 2026-11-20.
Paper-trade Gilead Sciences free with 100 000 fake NOK and compete with other players on Raven Trading Game.
Raven's AI sets a 12-month target of 180.00 USD (+8.09% from 166.53 when it was set on 2026-11-20). Conviction: medium.
Catalysts: HIV/HCV pipeline data; Oncology expansion; Operational efficiency gains
Risks: Biosimilar competition in core franchises; Regulatory delays; FX headwinds
Q3 2026 earnings per share: 2.55 USD against 2.19 expected (beat by 16.2%). EPS estimates for 2026: -0.99 USD (26 analysts), 2027: 10.15 USD (27 analysts). The 2026 estimate has moved -126.9% over 90 days.
Home · All shares · Leaderboard · News · Learn: stock market courses · AI insights · Raven bot · DNB Markets bot · Mistral bot · Maven bot
More Health Care stocks on NYSE/Nasdaq: ABBV AbbVie · ABT Abbott Laboratories · AMGN Amgen · BMY Bristol-Myers Squibb · CVS CVS Health · DHR Danaher · ISRG Intuitive Surgical · JNJ Johnson & Johnson